GenAI already a major component of care delivery

TORONTO – A new report, written by Will Falk (pictured) and published by CSA Group, argues that accelerated, supervised adoption of generative artificial intelligence (GenAI) in healthcare is both necessary and defensible. The balance of risk now favours a fast-paced but thoughtful bias toward implementation.

The report is titled “A Complement, Not a Substitute: Generative AI’s Role in Canadian Healthcare in 2026.” (Generative AI’s Role in Canadian Healthcare in 2026)

GenAI already offers practical leverage against longstanding system constraints. Clinicians are using generative tools to support documentation and information retrieval, while patients rely on them for explanation and navigation where the health system does not reliably perform these functions.

Attempts to pause or reverse this adoption in the name of caution are unlikely to improve safety and may exacerbate existing failures.

The report examines:

• Structural challenges in Canadian healthcare and where GenAI can help
• Adoption patterns in clinical practice, distinguishing complements from substitutes
• Early Canadian implementation lessons across healthcare sectors
• Key policy, regulatory and economic considerations
• While conclusions must remain provisional given rapid technological change, the evidence supports a clear direction – moving too slowly on GenAI in healthcare now poses greater risk than moving decisively with appropriate safeguards in place.

Access the report: Generative AI’s Role in Canadian Healthcare in 2026 https://www.csagroup.org/wp-content/uploads/CSA-AI-in-Healthcare-Policy-Report-EN_Accessible.pdf